Middle East and Africa Addictions Therapeutics Market

Market Introduction

Addiction is a psychological and physical inability to stop consuming drugs, alcohol, opioids, and related category substances, even though those substances have various mental and physical harms. An addiction develops dependency in a person to take that substance. So, to stop addictions, there are several options available such as drug therapy, rehabilitation, which can stop addiction in a better way.

Middle East and Africa Addictions Therapeutics Strategic Insights

Strategic insights for the Middle East and Africa Addictions Therapeutics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East and Africa Addictions Therapeutics Report Scope

Middle East and Africa Addictions Therapeutics Regional Insights

The geographic scope of the Middle East and Africa Addictions Therapeutics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Middle East and Africa Addictions Therapeutics market is expected to reach US$ 223.05 million in 2027 from US$ 172.05 million in 2019. The market is estimated to grow with a CAGR of 3.4% from 2020 to 2027. The growth of the market is attributed to rising approval of new drugs and launch of digital therapeutics to treat addiction, conduction of various awareness campaigns and government efforts to counteract drug abuse and promote medication. However, high cost associated with drug development is hindering the growth of the addiction therapeutics market.

Key Market Segments

Based on treatment type, the Europe addictions therapeutics market is segmented into nicotine addiction treatment, alcohol addiction treatment, opioid addiction treatment, and other substance addiction treatment. The nicotine addiction treatment segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

The Europe addictions therapeutics market, by drug type, is segmented into varenicline, bupropion, nicotine replacement products, buprenorphine, naltrexone, disulfiram, and others. The varenicline segment held the largest market share in 2019. However, the nicotine replacement products segment is anticipated to register the highest CAGR in the market during the forecast period.

Based on treatment center, the Europe addictions therapeutics market is segmented into outpatient treatment center, residential treatment center, and inpatient treatment center. In 2019, the outpatient treatment center segment held the largest share of the market and is estimated to register the highest CAGR in the market during the forecast period.

By distribution channel, the Europe addictions therapeutics market is segmented into hospital pharmacies, medical stores, and others. The hospital pharmacies segment held the largest share of the market in 2019. However, the medical stores segment is estimated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

Some of the primary and secondary sources associated with this report on the Middle East and Africa addictions therapeutics market are Federation of African Pharmaceutical Manufacturers’ Associations (FAPMA); Centers for Disease Control and Prevention (CDC); South African National Council on Alcoholism and Drug Dependence (SANCA) among others.

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of the Middle East and Africa addictions therapeutics market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Middle East and Africa addictions therapeutics market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East and Africa addictions therapeutics market.

MIDDLE EAST AND AFRICA ADDICTIONS THERAPEUTICS MARKET SEGMENTATION

 By Treatment Type

• Opioid Addiction Treatment
• Alcohol Addiction Treatment
• Nicotine Addiction Treatment
• Other Substance Addiction Treatment

By Drug Type

• Buprenorphine
• Naltrexone
• Bupropion
• Disulfiram
• Nicotine Replacement Products
• Varenicline
• Others

By Treatment Center

• Inpatient Treatment Center
• Residential Treatment Center
• Outpatient Treatment Center

By Distribution Channel

• Hospital Pharmacies
• Medical stores
• Others

By Country

• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East and Africa

Company Profiles

• Indivior PLC
• GlaxoSmithKline plc
• Bausch Health Companies Inc
• Cipla Inc.
• Alvogen
• Camurus AB
• Hikma Pharmaceuticals PLC